An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes-Reference-Cited by-同舟云学术

An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes

Published:2019-02-22 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sasaki Rina,Tainaka Reina,Ando Yuichi,Hashi Yurika,Deepak Hadya V.,Suga Yoshiko,Murai Yuta,Anetai Masaki,Monde Kenji^ORCID,Ohta Kiminori,Ito Ikuko,Kikuchi Haruhisa^ORCID,Oshima Yoshiteru,Endo Yasuyuki,Nakao Hitomi,Sakono Masafumi,Uwai Koji,Tokuraku Kiyotaka^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-38958-0.pdf

Reference31 articles.

1. Polanco, J. C. et al. Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies. Nat. Rev. Neurol. 14, 22–39, https://doi.org/10.1038/nrneurol.2017.162 (2018).

2. Koo, E. H., Lansbury, P. T. Jr. & Kelly, J. W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. USA 96, 9989–9990 (1999).

3. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356, https://doi.org/10.1126/science.1072994 (2002).